Related Experiment Video
Updated: Aug 6, 2026
06:46
Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
Agentic neurotechnology: A multi-agent AI framework for next-generation dementia care
Kevin Mekulu1, Faisal Aqlan2, Hui Yang1
1Complex Systems Monitoring Modeling and Control Laboratory Pennsylvania State University University Park Pennsylvania USA.
Alzheimer'S & Dementia (New York, N. Y.)
|July 23, 2026
Summary
Agentic Neurotechnology uses AI and continuous monitoring for proactive dementia care, addressing gaps in early detection and personalized support. This framework enhances cognitive care by integrating adaptive AI systems with longitudinal modeling.
Area of Science:
- Neuroscience
- Artificial Intelligence
- Digital Health
Background:
- Current dementia care tools are often episodic and disconnected from daily life, leading to missed early cognitive changes.
- There's a significant diagnostic gap for mild cognitive impairment (MCI) and a lack of continuous insights for care teams.
- Technological advancements in AI and digital biomarkers are outpacing clinical applications in dementia care.
Purpose of the Study:
- To introduce Agentic Neurotechnology, an integrated framework for proactive and individualized dementia care.
- To outline a five-layer agentic stack and the Cognitive Continuum Loop for continuous cognitive support.
- To identify actionable windows for cognitive intervention and propose a deployment pathway for agentic neurotechnologies.
Main Methods:
- Development of a five-layer agentic stack: sensing/biomarker agents, interpretation/reasoning agents, cognitive trajectory models, care navigation agents, and forecasting agents.
- Implementation of the Cognitive Continuum Loop for continuous detection, interpretation, reasoning, monitoring, intervention, and adaptation.
- Identification of three key intervention windows: Preclinical Risk Detection, MCI Detection, and Functional Instability Response.
Main Results:
- The proposed framework enables continuous, rather than isolated, assessments for dementia care.
- Agentic AI systems can operate continuously across different stages of cognitive decline.
- The framework supports proactive and individualized dementia care through integrated AI and cognitive modeling.
Conclusions:
- Agentic Neurotechnology reframes AI as an active partner in continuous cognitive care, moving beyond passive screening.
- The framework facilitates earlier detection, improved clinical efficiency, and personalized cognitive support.
- Deployment across various settings like assisted living, primary care, telehealth, and home-based care is proposed.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...